Table 2.
Formulation a | Final Lipid Content (mg/mL) | %EE | |
---|---|---|---|
Before Sonication | After Sonication | ||
E1 S60: Cho: ELP b |
10 | 22.1 ± 12.7 | 14.3 ± 1.3 |
E2 S60: Cho: ELP b |
40 | 32.9 ± 10.1 | 16.3 ± 3.5 |
E3 S60: Cho: ELP b |
40 | 40.1 ± 7.9 | 11.6 ± 4.5 |
E4 S60: Cho: ELP b |
80 | 27.9 ± 15.8 | 18.0 ± 14.5 |
L1 S60: Cho: L90 b |
40 | 10.5 ± 2.4 | 27.1 ± 1.4 |
For all experiments, n = 3. a All formulations E1, E2, E3, E4, and L1 were prepared at a molar ratio of 45:45:10. b Span® 60 (S60); cholesterol (Cho); Cremophor® ELP (ELP); Lauroglycol® 90 (L90).